CMA Gets Post-Brexit Cancer Drug Pricing Pact From Aspen
U.K. authorities reached a deal Wednesday allowing the country to enforce an agreement Aspen Pharmacare Holdings Ltd. cut with Europe's competition enforcer last year to lower prices for six cancer medications...To view the full article, register now.
Already a subscriber? Click here to view full article